{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "EMA EPAR|DISEASES" in comments (approximate match)
Status:
US Approved Rx
(2001)
Source:
BLA103948
(2001)
Source URL:
First approved in 2001
Source:
BLA103948
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2001)
Source:
BLA103951
(2001)
Source URL:
First approved in 2001
Source:
BLA103951
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2017)
Source:
BLA761060
(2017)
Source URL:
First approved in 2000
Source:
Mylotarg
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2000)
Source:
BLA103909
(2000)
Source URL:
First approved in 2000
Source:
BLA103909
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2000)
Source:
BLA103846
(2000)
Source URL:
First approved in 2000
Source:
BLA103846
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2002)
Source:
BLA103946
(2002)
Source URL:
First approved in 2000
Class:
PROTEIN
Status:
US Approved Rx
(2008)
First approved in 1999
Class:
PROTEIN
Status:
US Approved Rx
(2019)
Source:
BLA761073
(2019)
Source URL:
First approved in 1998
Source:
BLA103792
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2019)
Source:
BLA761086
(2019)
Source URL:
First approved in 1998
Source:
BLA103772
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(1998)
Source:
BLA103795
(1998)
Source URL:
First approved in 1998
Source:
BLA103795
Source URL:
Class:
PROTEIN
